| Literature DB >> 33197007 |
Florent Elefteriou1,2, Greig Couasnay3.
Abstract
The Cre-LoxP technology permits gene ablation in specific cell lineages, at chosen differentiation stages of this lineage and in an inducible manner. It has allowed tremendous advances in our understanding of skeleton biology and related pathophysiological mechanisms, through the generation of loss/gain of function or cell tracing experiments based on the creation of an expanding toolbox of transgenic mice expressing the Cre recombinase in skeletal stem cells, chondrocytes, osteoblasts, or osteoclasts. In this chapter, we provide an overview of the different Cre-LoxP systems and Cre mouse lines used in the bone field, we discuss their advantages, limitations, and we outline best practices to interpret results obtained from the use of Cre mice.Entities:
Keywords: Chondrocytes; Cre-recombinase; Floxed gene; Mouse model; Off target; Osteoblasts; Osteoclasts; Osteocytes; Specificity; Transgenic mice
Mesh:
Substances:
Year: 2021 PMID: 33197007 DOI: 10.1007/978-1-0716-1028-2_3
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745